SNP GENOTYPING AND ANALYSIS MARKET ANALYSIS

Regional Analysis

Global SNP Genotyping And Analysis Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global SNP genotyping and analysis market over the forecast period. North America holds 35.2% of the market share, attributed to the increading burdern of chronic disorder. Genotyping techniques can be utilized for early diagnosis and treatment of chronic diseases. According to the 2022 report from the National Association of Chronic Disease Directors, about 60% of adult Americans have at least one chronic disease. Diabetes, cancer, and cardiovascular disease are among the top causes of death in the United States. One or more of the following five chronic diseases account for more than two-thirds of all deaths: heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes. According to the CDC, people with chronic diseases and mental health disorders account for 90% of the nation's US$ 3.8 trillion in annual healthcare costs.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa